Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain-Barré syndrome.
(2024) European journal of neurology — Vol. 31, n° 4, p. e16230 [1-2] (2024)
Files
2024_Van_Doorn_Eur_J_Neurol.pdf
Open Access - Adobe PDF
- 202.21 KB
Details
- Authors
van Doorn, Pieter A 
Van den Bergh, Peter Hadden, Robert D M
- Abstract
- DEAR EDITOR, We respond to the letter of Drs. Li and Lu regarding the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) Guideline on diagnosis and treatment of Guillain–Barré syndrome (GBS). Their question is why the GBS Guideline Task Force (TF) made a strong recommendation against the administration of a second course of intravenous immunoglobulins (IVIg; second immunoglobulin dose [SID]) in GBS patients with a poor prognosis. [...]
- Affiliations
Citations
van Doorn, P. A., Van den Bergh, P., & Hadden, R. D. M. (2024). Response to letter on European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of Guillain-Barré syndrome. European journal of neurology, 31(4), e16230 [1-2]. https://doi.org/10.1111/ene.16230 (Original work published 2024)